JPMorgan Chase & Co’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Sell |
|
|||||
|
2025
Q1 | $20.7K | Sell |
|
|||||
|
2024
Q4 | $77K | Buy |
|
|||||
|
2024
Q3 | $84.2K | Buy |
|
|||||
|
2024
Q2 | $26.5K | Buy |
|
|||||
|
2024
Q1 | $4.47K | Buy |
|
|||||
|
2023
Q4 | $3.03K | Buy |
|
|||||
|
2023
Q3 | $179 | Buy |
|
|||||
|
2023
Q2 | $62 | Hold |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Hold |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Hold |
|
|||||
|
2022
Q1 | $0 | Hold |
|
|||||
|
2021
Q4 | $0 | Hold |
|
|||||
|
2021
Q3 | $0 | Hold |
|
|||||
|
2021
Q2 | $0 | Sell |
|
|||||
|
2021
Q1 | $218K | Sell |
|
|||||
|
2020
Q4 | $232K | Buy |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $85K | Sell |
|
|||||
|
2020
Q1 | $79K | Buy |
|
|||||
|
2019
Q4 | $38K | Hold |
|
|||||
|
2019
Q3 | $48K | Buy |
|
|||||
|
2019
Q2 | $41K | Sell |
|
|||||
|
2019
Q1 | $964K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $165K | Buy |
|